Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |